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Abstract 
Fine needle aspiration biopsy (FNAB) offers a simple outpatient technique for specimen collection 
in child tuberculosis suspects with peripheral lymphadenopathy. To perform FNAB with 
mycobacterial culture on an outpatient basis requires use of a sterile transport medium to facilitate 
bedside inoculation, maintain organism viability and reduce contamination risk en route to the 
laboratory. The mycobacterial yield and time to positive culture following bedside inoculation into 
standard mycobacterial growth indicator tubes were compared with initial inoculation into an 
inexpensive “in-house” liquid growth medium. Of 150 FNAB performed, 57 (38%) cultured 
Mycobacterium tuberculosis complex. There was one case each with non-tuberculous mycobacteria 
and Mycobacterium bovis BCG; the remaining 55 being M tuberculosis. Results were concordant in 
142 (94.7%) bedside and laboratory inoculation pairs. There was no significant difference in time to 
positive culture between bedside and laboratory inoculation (16.2 days (SD 0.87) vs 17.1 days (SD 
0.85)). Provision of inexpensive specimen transport bottles and practical tuition in FNAB should 
improve cost-effective diagnosis of tuberculosis at the primary healthcare level.  
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 Tuberculosis may be extrapulmonary in 10–30% children,1 and tuberculous lymphadenitis is the 
most common extrapulmonary manifestation of tuberculosis in endemic areas;2 5–10% of children 
may have tuberculous adenitis in association with pulmonary involvement.3 This provides an 
excellent opportunity to obtain bacteriological confirmation using fine needle aspiration biopsy 
(FNAB).4 FNAB is a simple and safe outpatient procedure that can be performed by nurses in 
resource-limited settings5 and provides material for direct microscopy as well as culture and 
susceptibility testing. Cultures from FNAB specimens in children give a greater yield in a shorter 
time, compared with conventional respiratory specimens such as gastric washings.6 
Direct bedside inoculation of FNAB specimens is ideal, and excellent results have been obtained 
with commercial liquid media systems such as mycobacterial growth indicator tubes (MGIT; 
Beckton Dickinson, Sparks, Maryland, USA).4 This practice, however, is limited by cost and 
availability.4 We aimed to develop a simple and cheap mycobacterial transport medium and then 
to compare the bacteriological yield and time to positive culture achieved with direct bedside 
inoculation into MGIT versus initial use of the transport medium.  
Materials and methods 
All adults and children referred to the FNAB Clinic at Tygerberg Hospital, Cape Town, South Africa 
(June 2007–May 2008) with clinical mycobacterial lymphadenitis and in whom written informed 
consent to participate in the study was obtained (following ethics approval) were included.  
Tuberculosis transport bottles, containing 1 ml aliquots of Middlebrook 7H9 broth (with 0.2% 
glycerol and 0.05% Tween 80 added) in 10 ml headspace glass vials, were prepared “in house” 
(Biomedical TB Research Unit by a study scientist, KGPH) in a laminar flow cabinet, sealed with 20 
mm TFE/Sil Septa and 20 mm aluminium open top seals and autoclaved at 120°C/20 minutes (fig 1). 
Unlike the MGIT tube, the transport bottle does not require removal of the lid, minimising the risk 
of contamination.  
FNAB was carried out following standard protocol.4 Two needle passes were performed: from the 
first, cytology slides were prepared before the syringe and needle were rinsed by withdrawing an 
aliquot of liquid growth medium into the syringe and then expelling the contents back into the 
MGIT tube (bedside inoculation or control). After transport to the laboratory within the same 
hospital, within 2–24 h, the MGIT tube was incubated in a BACTEC MGIT 960 machine for 42 days.  
What this study adds 
 A simple and inexpensive means to obtain mycobacterial culture from FNAB 
specimens was developed using an “in-house” liquid growth medium for 
transport to the laboratory.  
 Transporting FNAB material to the laboratory in the “in-house” medium was 
similar to a commercial medium with respect to culturing mycobacteria and in 
time to positive culture.  
 Similar results were obtained when the “in-house” transport bottle was kept 
at room temperature for 7 days before culturing for mycobacteria.  
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From the second FNAB pass, slides were prepared for cytology and the syringe and needle were 
rinsed into the tuberculosis transport bottle. In the laboratory, 0.5 ml was aspirated from the 
transport bottle, inoculated into a separate MGIT tube (immediate laboratory inoculation) and 
incubated as above. In a subset of consecutive samples, the transport bottle was held at room 
temperature (12–30°C) for 7 days after which subculture was performed as described above 
(delayed laboratory inoculation). The delayed inoculation group was designed to mimic the 
situation of rural clinics where specimens may take some days to reach the laboratory.  
PANTA antibiotic mixture (containing polymixin B, amphotericin B, nalidixic acid, trimethoprim and 
azlocillin; Becton Dickinson) was added to all MGIT tubes before incubation. All positive MGIT tubes 
were confirmed to contain acid fast bacilli in the absence of bacterial contamination, followed by 
accurate PCR speciation.7 The mycobacterial yield and time to positive culture in the respective 
MGIT tubes were compared using Statistica version 8 software and the χ2 test.  
Results 
Over the period of one year 150 FNAB were performed, and 24.5% of these were in patients less 
than 16 years, the youngest being 5 months old. Mycobacterium tuberculosis complex was cultured 
in 57 patients (38%). There was one case each of non-tuberculous mycobacteria (NTM) and 
Mycobacterium bovis BCG, with the remaining 55 being M tuberculosis, consistent with the profile 
of disease in our population.3 4 8  In the tuberculosis culture-negative patients there were an 
additional 12 cases (11.4%) positive on cytology (morphological evidence of mycobacterial infection 
and identification of the organism). In 17 patients there was a specific diagnosis other than 
mycobacterial infection, made on cytology, 13 of these were malignant neoplasms.  
The results of culture were concordant in 142 (94.7%) bedside and laboratory inoculation pairs, 
with eight discordant pairs: three were positive on bedside inoculation only and five were positive 
on laboratory inoculation only. In one of the discordant pairs, positive on bedside inoculation and 
negative on laboratory inoculation, there was inadequate material on the cytology slides. There was 
no significant difference in time to positive culture between the bedside and laboratory inoculation 
tubes (16.2 days (SD 0.87) vs 17.1 days (SD 0.85)).  
There were 31 pairs with matched immediate and delayed laboratory inoculation culture results, of 
which 29 were concordant (93.6%). The two discordant pairs showed no growth in the delayed 
culture, compared with growth in bedside and immediate laboratory cultures; both had required 
repeated decontamination due to bacterial contamination introduced in the laboratory. There was 
no significant difference in time to positive culture between the immediate and delayed laboratory 
inoculation groups (table 1).  
Discussion 
Although FNAB has been shown to be an excellent method for obtaining specimens for culture as 
well as cytology, the method for transporting specimens to the laboratory is rarely specified.9 
Mycobacteria need to remain viable during transportation if culture is to be successful and 
traditional methods for the preservation of specimens, eg, refrigeration10 are not applicable to 
FNAB specimens in resource-poor settings. In most patients FNAB yields insufficient material to 
express into a sterile tube, and commercial liquid culture media, eg, BACTEC Myco/F Lytic are 
recommended only for blood and body fluids.11 Submission of the syringe (with or without the 
needle attached) directly to the laboratory compromises the quality of the specimen and puts 
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healthcare workers at risk. This practice is unacceptable, especially in settings with a high 
prevalence of multidrug-resistant tuberculosis and/or HIV.  
Rinsing the needle and syringe in commercial liquid culture medium, such as MGIT, is very 
successful in obtaining a positive culture.4 5 However, the widespread distribution of MGIT tubes is 
limited by issues of cost and storage requirements. These tubes need to be stored in the dark and 
removal of the cap for inoculation outside the laboratory increases the risk of contamination. This 
study suggests that subculture from a tuberculosis transport bottle, even after a 7-day delay, gives 
similar yields in a similar time period, to direct bedside inoculation. The few discrepancies (8/150) 
noted between the bedside and laboratory cultures may be due to random sampling differences as 
the tubes were inoculated from separate needle passes.  
The transport medium described in this study is inexpensive (MGIT tube US$4 vs US$1 tuberculosis 
transport bottle, 2008 prices in South Africa), easy to prepare “in house”, does not require 
refrigeration as it is stable through a range of temperatures, and does not require removal of the lid 
for inoculation. Transport of these specimens from rural clinics may follow the same route as other 
laboratory specimens such as sputum and peripheral blood. The positive culture yield and the time 
to positive culture from the transport medium, even after 7 days at room temperature, are 
statistically comparable with direct bedside inoculation into MGIT tubes. The production and 
distribution of these bottles to clinics and hospitals, combined with practical tuition in the optimal 
performance of FNAB, will have a positive impact on the cost-effective diagnosis of tuberculosis at 
the primary healthcare level.  
Table 
Table 1  
The mycobacterial yield and time to positive culture achieved with FNAB and variable timing of 
MGIT inoculation. 
Timing of MGIT inoculation 
Total no 
specimens 
Mycobacterial 
culture 
Time to positive culture 
Positive Negative 
Mean 
days 
SD 95% CI 
Bedside versus immediate laboratory inoculation from transport bottle 
Bedside 150 
53 
(35.3%) 
97 
(64.7%) 
16.2 0.87 
16.8 to 
20.3 
Immediate laboratory 150 
55 
(36.7%) 
95 
(63.3%) 
17.1 0.85 
15.7 to 
19.1 
Subset-matched pairs: delayed versus immediate laboratory inoculation from transport bottle 
Delayed laboratory (day 7) 31 
11 
(35.5%) 
20 
(64.5%) 
17.1 1.36 
14.1 to 
20.1 
Immediate laboratory (day 
0) 
31 
13 
(41.9%) 
18 
(58.1%) 
16.2 1.31 
13.3 to 
19.2 
 FNAB, fine needle aspiration biopsy; MGIT, mycobacterial growth indicator tube. 
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Figure 
Figure 1 
Tuberculosis transport bottle. 
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